SCM
STML

Suvretta Capital Management’s Stemline Therapeutics, Inc. STML Stock Holding History

Suvretta Capital Management’s Portfolio STML Stock Details STML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-295,500
Closed -$1.43M – 108
2020
Q1 		$1.43M Buy
+295,500
New +$1.92M 0.04% 44

Suvretta Capital Management's STML Position: Q2 2020 in Review

Suvretta Capital Management sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 295,500 shares — an estimated $1.43M sold.

Suvretta Capital Management first reported a position in STML in Q1 2020 and held it in 1 quarter. The position peaked at $1.43M in Q1 2020. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

  • Suvretta Capital Management reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
  • Suvretta Capital Management sold 295,500 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $1.43M.
  • Suvretta Capital Management first reported a position in Stemline Therapeutics, Inc. in Q1 2020 and held it in 1 quarter.
  • Suvretta Capital Management's Stemline Therapeutics, Inc. position peaked at $1.43M in Q1 2020.
  • 0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Suvretta Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.